Evidence map›Paper›PMID 28699227›Full record

ArticleCancer science2017

Implication of chemo-resistant memory T cells for immune surveillance in patients with sarcoma receiving chemotherapy.

Yuji Shibayama, Tomohide Tsukahara, Makoto Emori, Kenji Murata, Emi Mizushima, Yoshihiko Hirohashi, Takayuki Kanaseki, Munehide Nakatsugawa, Terufumi Kubo, Toshihiko Yamashita and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Apoptosis: aJournal for immunotherapy of cancer · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yuji ShibayamaDepartment of Pathology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.
Tomohide TsukaharaDepartment of Pathology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.ORCID http://orcid.org/0000-0002-3678-4359
Makoto EmoriDepartment of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.
Kenji MurataDepartment of Pathology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.
Emi MizushimaDepartment of Pathology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.
Yoshihiko HirohashiDepartment of Pathology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.
Takayuki KanasekiDepartment of Pathology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.
Munehide NakatsugawaDepartment of Pathology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.
Terufumi KuboDepartment of Pathology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.
Toshihiko YamashitaDepartment of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.
Noriyuki SatoDepartment of Pathology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.
Toshihiko TorigoeDepartment of Pathology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.
Sapporo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy has improved the prognosis of patients with sarcomas. However, it may suppress anti-tumor immunity. Recently, we reported a novel CD8

Indexed as

Immunologic MemoryAdolescentAdultAgedAged, 80 and overAntigens, NeoplasmAntineoplastic AgentsCase-Control StudiesCD8-Positive T-LymphocytesChildChild, PreschoolDrug Resistance, NeoplasmFemaleHumansMaleMiddle AgedAntigens, NeoplasmAntineoplastic AgentsChemotherapyperipheral bloodsarcomastem cell memoryyoung memory

Identifiers

PMID28699227
PMCPMC5581517
OpenAlexW2735025483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.